Press Resease

Veterinary Anti-Infectives Market - Global Industry Analysis

Veterinary Anti-Infectives Market By Animal Type (Livestock and Pet), By Drug Class (Antibacterial, Antimicrobial, Antiviral, Antifungal and Antiparasitic Agents), By Mode of Administration (Oral, Parenteral and Topical): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 21-Apr-2021 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2510 Status : Published

The global veterinary anti-infectives Market accounted for USD 5,626.1 Million in 2020 and is expected to reach USD 9,259.3 Million by 2028, growing at a CAGR of 6.8% from 2021 to 2028.

Description

Market Overview

The global veterinary anti-infectives Market accounted for USD 5,626.1 Million in 2020 and is expected to reach USD 9,259.3 Million by 2028, growing at a CAGR of 6.8% from 2021 to 2028.

Anti-Infectives are products which help in preventing spread or transmission of diseases. And veterinary anti-infectives are products which prevent or cures spreading of animal infectious diseases to humans. The increase in demand for animal products such as meat, milk, etc. consumption and the diseases related to these animals have promoted the use of anti infectives.

The increases in foodborne diseases are one of the key market drivers for anti-infectives. 75 percent of all infectious diseases are infact animal borne and spread to humans from them. These diseases are health hazards to humans and are prime concerns of public health department to control them. The adoption culture is increasing over the globe especially dogs and cats and the issues related to their health and hygiene is also one of the factors promoting anti-infectives market.

COVID-19 Impact Analysis

The global veterinary anti-infectives has witnessed a downturn in the sales for short term owing to the hindered possibilities of not being able to export cattle meat, dairy product, etc. produced in various countries due to lockdown enforcement. The decline in supply of animal products has also led to decline for veterinary anti-infectives. The restrictions imposed by various nations to contain COVID had stopped the production resulting in a disruption across the whole supply chain. However, the world markets are slowly opening to their full potential and theirs a surge in demand of veterinary anti-infectives. The market would remain sluggish in upcoming year but it is expected to gain momentum due to the rise in demand of animal products, consumption of animal products are as normal as before COVID pandemic. COVID 19 is a perfect example of what disaster these animal borne diseases can do to humans.

Growth Factors

The growing demand for pet animals and their health care is one major part of global veterinary anti-infectives. Pets like dogs and cats are very susceptible to bacterial diseases, such as plague etc. Studies have shown us that they can pass on these to humans, which is why there is increase in number of vaccinations for pets, control and cure of acquired diseases by them. There are researches going on to develop new and more effective drugs. Clinical trials are being conducted to test the efficiency of these new drugs.

The Livestock and cattle market which is largest single consumer of anti-infectives. The eating habits of people are such that they will consume meat in any from and there are various diseases that can be transmitted to us from these products.  Rural people are getting more and more aware of anti-infectives which are benefiting them and the manufactures. Rural people hold cattle’s in huge numbers for their consumptions are mostly unaware of the infectious disease these cattle’s carry on them.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Animal Type Segment Analysis Preview

Livestock segment held a share of around 65.41% in 2020. Livestock can further be sub segmented into poultry, pork, beef, fish, seafood, etc. This segments growth is attributable to the significant increase in meat and non-vegetarian items consumption. This segment is going to see largest increase because of above factor.

Drug Segment Analysis Preview

Antibacterials in drug will grow at a CAGR of over 5.5% from 2021 to 2028. This is attributable to the number of bacterial infections in livestock and pet segment. There are new developments in the drug segment. Researches are being conducted to test their potency or effectiveness.

Antiviral is also set to see demand in the market as pets are very prawn to viral infections such as rabies, yellow fever and pappataci fever, etc. if not treated on time it can pass on to humans easily. Dogs are the prime example as they account for 90plus percent of rabies transmitted to humans.

Oral mode of administration is the largest segment in mode of administration. This is mainly due to convince, its hassle free and less messy than mode of administration.

Regional Analysis Preview

The North American region held a share of 1,741.8% in 2020. This is attributable to the presence of top companies such as Pfizer Inc, Brystol Myers Squibb Company, Johnson and Johnson Services Inc among others. This is associated to the advanced technological progress this region has made over the course of time. North America is home to world’s largest exotic pets market.   Moreover, the increasing usage of veterinary anti-infectivesexpected to generate huge demand for the market in this region.

The Asia Pacific region is projected to grow at a CAGR of 7.7% over the forecast period. This surge is due to the increasing awareness among common people regarding the benefits of using veterinary anti-infectivesto their benefit.  APAC region is also one of the major exporters of livestock, for which they have to keep a check that they are not infected to any unwanted things. APAC region is also seeing an increase in number of pets which will be a major reason for market growth in this region.

Key Market Players & Competitive Landscape.

 Some of key players in global veterinary anti-infectivesmarket are Pfizer Inc, Merck and Co., Ltd, Brystol Myers Squibb Company, Abbott, Novartis AG, Johnson and Johnson Services Inc, Gilead Sciences, Inc, Astellas Pharma Inc, GlaxoSmithKline plc, Gilead Sciences, AbbVie, Bayer AG, Boehringer Ingelheim GmbH, Ceva Santé Animale, Elanco and among others.

Zoetis Inc. and Regeneron Pharmaceuticals, Inc have signed a pact around mid-2018, they are going to collaborate for antibody technology for next five years

The global veterinary anti-infectivesis segmented as follows:

By Animal Type

  • Livestock
  • Pet or Companion

By Drug Class

  • Antibacterial
  • Antimicrobial
  • Antiviral
  • Antifungal
  • Antiparasitic

By Mode of Administration

  • Oral
  • Parenteral
  • Topical

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Animal Type
        • 2.1.1.2. Market Attractiveness Analysis, By Drug Class
        • 2.1.1.3. Market Attractiveness Analysis, By Mode Of Administration
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Veterinary Anti-Infectives Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Veterinary Anti-Infectives Market – Animal Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Animal Type, 2020 & 2028
    • 4.2. Livestock
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Pet or Companion
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Veterinary Anti-Infectives Market – Drug Class Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Drug Class, 2020 & 2028
    • 5.2. Antibacterial
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Antimicrobial
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Antiviral
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Antifungal
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Antiparasitic
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Veterinary Anti-Infectives Market – Mode Of Administration Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Mode Of Administration, 2020 & 2028
    • 6.2. Oral
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Parenteral
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Topical
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Veterinary Anti-Infectives Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Animal Type, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Drug Class, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Animal Type, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Drug Class, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Animal Type, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Drug Class, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Animal Type, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Drug Class, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Animal Type, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Drug Class, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Animal Type, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Drug Class, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Animal Type, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Drug Class, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Animal Type, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Drug Class, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Animal Type, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Drug Class, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Animal Type, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Drug Class, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Animal Type, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Drug Class, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Animal Type, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Drug Class, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Mode Of Administration, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Animal Type, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Drug Class, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Animal Type, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Drug Class, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Animal Type, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Drug Class, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Mode Of Administration, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Animal Type, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Drug Class, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Mode Of Administration, 2016 – 2028
  • Chapter No. 8 Veterinary Anti-Infectives Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Veterinary Anti-Infectives Market: Company Market Share, 2019
      • 9.1.2. Global Veterinary Anti-Infectives Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Veterinary Anti-Infectives Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Veterinary Anti-Infectives Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Pfizer Inc
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Merck and Co Ltd
    • 10.3. Brystul Myers Squibb Company
    • 10.4. Abbott
    • 10.5. Novartis AG
    • 10.6. Johnson and Johnson Services Inc
    • 10.7. Gilead Sciences Inc
    • 10.8. Astellas Pharma Inc
    • 10.9. GlaxoSmithKline plc
    • 10.10. Gilead Sciences
    • 10.11. AbbVie
    • 10.12. Bayer AG
    • 10.13. Boehringer Ingelheim GmbH
    • 10.14. Ceva Santé Animale
    • 10.15. Elanco
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Component
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By End Use Industry
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Veterinary Anti-Infectives Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North American Countries
FIG NO. 7. Market Revenue Share, By Component, 2020 & 2028
FIG NO. 8. Global Veterinary Anti-Infectives Market for Software, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Software, By Country, 2020 & 2028
FIG NO. 10. Global Veterinary Anti-Infectives Market for Service, Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Service, By Country, 2020 & 2028
FIG NO. 12. Global Veterinary Anti-Infectives Market Revenue Share, By Application, 2020 & 2028
FIG NO. 13. Global Veterinary Anti-Infectives Market for Marketing, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Marketing, By Country, 2020 & 2028
FIG NO. 15. Global Veterinary Anti-Infectives Market for Operations, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Operations, By Country, 2020 & 2028
FIG NO. 17. Global Veterinary Anti-Infectives Market for Finance, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Finance, By Country, 2020 & 2028
FIG NO. 19. Global Veterinary Anti-Infectives Market for Human Resource, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Human Resource, By Country, 2020 & 2028
FIG NO. 21. Global Veterinary Anti-Infectives Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Others, By Country, 2020 & 2028
FIG NO. 23. Global Veterinary Anti-Infectives Market Revenue Share, By End Use Industry, 2020 & 2028
FIG NO. 24. Global Veterinary Anti-Infectives Market for Manufacturing, Revenue (USD Million) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Manufacturing, By Country, 2020 & 2028
FIG NO. 26. Global Veterinary Anti-Infectives Market for Hospitality, Revenue (USD Million) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Hospitality, By Country, 2020 & 2028
FIG NO. 28. Global Veterinary Anti-Infectives Market for BFSI, Revenue (USD Million) 2016 – 2028
FIG NO. 29. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for BFSI, By Country, 2020 & 2028
FIG NO. 30. Global Veterinary Anti-Infectives Market for Retail, Revenue (USD Million) 2016 – 2028
FIG NO. 31. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Retail, By Country, 2020 & 2028
FIG NO. 32. Global Veterinary Anti-Infectives Market for IT & Telecom, Revenue (USD Million) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for IT & Telecom, By Country, 2020 & 2028
FIG NO. 34. Global Veterinary Anti-Infectives Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Veterinary Anti-Infectives Market for Others, By Country, 2020 & 2028
FIG NO. 36. Global Veterinary Anti-Infectives Market Revenue Share, By Region, 2020 & 2028
FIG NO. 37. North America Veterinary Anti-Infectives Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 38. Porter’s Five Forces Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 39. PEST Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 40. Pricing Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 41. Value Chain Analysis for Global Veterinary Anti-Infectives Market
FIG NO. 42. Company Share Analysis, 2019
FIG NO. 43. Radar Determinant Chart, 2019
FIG NO. 44. Company Strategic Developments – Heat Map Analysis
FIG NO. 45. Oracle Corporation Business Segment Revenue Share, 2020 (%)
FIG NO. 46. Oracle Corporation Geographical Segment Revenue Share, 2020 (%)
FIG NO. 47. Market Channels
FIG NO. 48. Marketing Channel Development Trend
FIG NO. 49. Growth in World Gross Product, 2008-2018
FIG NO. 50. Research Methodology – Detailed View
FIG NO. 51. Research Methodology
 


List of Tables 

TABLE NO. 1. Global Veterinary Anti-Infectives Market: Snapshot
TABLE NO. 2. Quarterly Veterinary Anti-Infectives Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Veterinary Anti-Infectives Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Veterinary Anti-Infectives Market for Software, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Veterinary Anti-Infectives Market for Service, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Veterinary Anti-Infectives Market for Marketing, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Veterinary Anti-Infectives Market for Operations, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Veterinary Anti-Infectives Market for Finance, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Veterinary Anti-Infectives Market for Human Resource, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Veterinary Anti-Infectives Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Veterinary Anti-Infectives Market for Manufacturing, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Veterinary Anti-Infectives Market for Hospitality, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Veterinary Anti-Infectives Market for BFSI, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Veterinary Anti-Infectives Market for Retail, by Region, 2016 – 2028 (USD Million)
TABLE NO. 17. Global Veterinary Anti-Infectives Market for IT & Telecom, by Region, 2016 – 2028 (USD Million)
TABLE NO. 18. Global Veterinary Anti-Infectives Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 19. Global Veterinary Anti-Infectives Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 20. North America Veterinary Anti-Infectives Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 21. North America Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 22. North America Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 23. North America Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 24. U.S. Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 25. U.S. Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 26. U.S. Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 27. Canada Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 28. Canada Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 29. Canada Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 30. Mexico Veterinary Anti-Infectives Market Revenue, By Component, 2016 – 2028 (USD Million)
TABLE NO. 31. Mexico Veterinary Anti-Infectives Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 32. Mexico Veterinary Anti-Infectives Market Revenue, By End Use Industry, 2016 – 2028 (USD Million)
TABLE NO. 33. Drivers for the Veterinary Anti-Infectives Market: Impact Analysis
TABLE NO. 34. Restraints for the Veterinary Anti-Infectives Market: Impact Analysis
TABLE NO. 35. Major Buyers of Veterinary Anti-Infectives
TABLE NO. 36. Distributors/Traders List of Veterinary Anti-Infectives
TABLE NO. 37. Global Veterinary Anti-Infectives Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 38. Global Veterinary Anti-Infectives Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Veterinary Anti-Infectives market. Zion Research has collected and analyzed key data belong to the global Veterinary Anti-Infectives market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Veterinary Anti-Infectives across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Veterinary Anti-Infectives industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Veterinary Anti-Infectives market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Anti-infectives are chemical substances capable of combating malfunction caused due to foreign bacteria such as Corona and Salmonella. These substances act in order to inhibit, prevent, and completely cure bacterial animal infections. Application of biological anti-infective makes the animal’s body immune from a particular bacterial infection, and also prevents future chances of contracting the infection. Veterinary pharmaceutical companies offer various products such as antibiotics, vaccines, parasiticides, medical feed additives and others. Of all product types, anti-infective formulations are more used by veterinary doctors. In recent years, studies have shown how fatal veterinary diseases are not limited to wild species, but may also occur in domestic animals. Increasing incidence of zoonotic and food-borne disorders and the need of mitigating such diseases is projected to render an exponential growth for veterinary therapeutics, including veterinary anti-infectives drug market.

Specialty and biologic care are offering huge investment opportunities for key players in anti-infectives market. Due to the aged product portfolio, the market anticipates NPD (New Product Development) in urgency. Entry of new market players and launch of abridged formulations, followed by changing distribution channels, a considerable rise in pet insurance, and competitive branded products for animal health care are collectively observed as key facets in this market. Improvised research & development methods in biologics will provide a huge array of opportunities in the market. Availability of generic drugs at affordable prices and increased end-user awareness for pet care is also offering significant growth opportunities for the veterinary anti-infective market.

Global-Veterinary-Anti-Infectives-Market.png

Based on species type, veterinary anti-infectives market has been segmented into livestock and companion animals. On the basis of drug type, the market for veterinary anti-infectives is segmented into antimicrobial, antiviral, antifungal and antiparasitic agents. By mode of administration, the market for veterinary anti-infectives is segmented into oral, parenteral and topical. Based on end-user the veterinary anti-infectives market is segmented into veterinary hospitals, veterinary clinics, pharmacies and others.  

Increasing pet ownership and vigorous demand for improved animal nutrition are fueling the veterinary anti-infective market in North America. Balancing the animal’s nutrition with use of anti-infectives has proven to improve the immunity of animals, and help them in gaining resistance against most infections. In North America, people are more concerned about the health of their pet animal or livestock, so their focus on food safety, which is another influencing factor associated with higher nutritional demand in the global market for veterinary anti-infectives. Owing to high awareness, end-users continue to prefer drugs that are FDA-approved. Newly-launched generic drugs are estimated to increase market share for anti-infectives in the Asia Pacific. Moreover, the presence of generic companies and increasing level of disposable income is also expected to fuel the market’s growth further in this region.

Some of the key players in Veterinary Anti-Infectives market include ACG Worldwide, Bright Pharma Caps, Inc., CapsCanada, Capsugel, Healthcaps India Ltd., Qualicaps LLC, Suheung Co., Ltd. and Sunil Healthcare Limited. Investments in R&D and new manufacturing units for veterinary anti-infectives in economically stable countries and acquisitions and collaborations with manufacturers in different regions are other key differentiating strategies of the leading market players.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social